abstract |
The invention describes a pharmaceutical composition which can be administered to the mucous membranes, comprising a pharmacologically active calcitonin, isocapropyl (Ala7, Aib10.17, Lys (For) 11.18, Lys (deoxyfructosyl) 24) - salmon calcitonin - (5-32), which, when administered through the mucous membranes, for example by the oral route, has powerful hypocalcemic effects. |